{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:09:59Z","timestamp":1782961799004,"version":"3.54.5"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.xphs.2021.02.030","type":"journal-article","created":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T10:54:00Z","timestamp":1614423240000},"page":"2555-2561","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Nanoemulsion for Improving the Oral Bioavailability of Hesperetin: Formulation Optimization and Absorption Mechanism"],"prefix":"10.1016","volume":"110","author":[{"given":"Fanyu","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhining","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yike","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20133","key":"10.1016\/j.xphs.2021.02.030_bib0001","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0169-409X(96)00427-9","article-title":"Applications of the Caco-2 model in the design and development of orally active drugs: elucidation of biochemical and physical barriers posed by the intestinal epithelium","volume":"23","author":"Gan","year":"1997","journal-title":"Adv. Drug Deliv. Rev"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2021.02.030_bib0002","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0168-3659(99)00034-6","article-title":"Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery","volume":"62","author":"Benet","year":"1999","journal-title":"J. Control Release"},{"issue":"4","key":"10.1016\/j.xphs.2021.02.030_bib0003","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/sj.ejcn.1602543","article-title":"Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects","volume":"61","author":"Kanaze","year":"2007","journal-title":"Eur J Clin Nutr"},{"issue":"13","key":"10.1016\/j.xphs.2021.02.030_bib0004","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1021\/jf050054y","article-title":"Bioavallability and antioxidant effects of orange juice components in humans","volume":"53","author":"Franke","year":"2005","journal-title":"J. Agric. Food Chem"},{"issue":"3","key":"10.1016\/j.xphs.2021.02.030_bib0005","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ptr.5256","article-title":"Antioxidant and anti-inflammatory properties of the citrus flavonoids hesperidin and hesperetin: an updated review of their molecular mechanisms and experimental models","volume":"29","author":"Parhiz","year":"2015","journal-title":"Phytother Res"},{"issue":"5","key":"10.1016\/j.xphs.2021.02.030_bib0006","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1474-9726.2006.00233.x","article-title":"Modulation of the age-related nuclear factor-kappa B (NF-kappa B) pathway by hesperetin","volume":"5","author":"Kim","year":"2006","journal-title":"Aging Cell"},{"issue":"12","key":"10.1016\/j.xphs.2021.02.030_bib0007","doi-asserted-by":"crossref","first-page":"e22588","DOI":"10.1002\/jbt.22588","article-title":"Hesperetin ameliorates lipopolysaccharide-induced acute lung injury via the miR-410\/SOX18 axis","volume":"34","author":"Dong","year":"2020","journal-title":"J. Biochem. Mol. Toxicol"},{"issue":"5","key":"10.1016\/j.xphs.2021.02.030_bib0008","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1517\/17425247.2012.668523","article-title":"Exploring oral nanoemulsions for bioavailability enhancement of poorly water-soluble drugs","volume":"9","author":"Kotta","year":"2012","journal-title":"Expert Opin Drug Deliv"},{"issue":"2","key":"10.1016\/j.xphs.2021.02.030_bib0009","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1080\/03639045.2017.1391831","article-title":"Formulation optimization and the absorption mechanisms of nanoemulsion in improving baicalin oral exposure","volume":"44","author":"Wu","year":"2018","journal-title":"Drug Dev Ind Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2021.02.030_bib0010","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jconrel.2010.10.013","article-title":"Nanoemulsion improves the oral absorption of candesartan cilexetil in rats: performance and mechanism","volume":"149","author":"Gao","year":"2011","journal-title":"J.Control. Release"},{"issue":"3","key":"10.1016\/j.xphs.2021.02.030_bib0011","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2217\/nnm-2017-0277","article-title":"Paeonol nanoemulsion for enhanced oral bioavailability: optimization and mechanism","volume":"13","author":"Chen","year":"2018","journal-title":"Nanomedicine"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2021.02.030_bib0012","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0168-3659(02)00049-4","article-title":"Microemulsion formulation for enhanced absorption of poorly soluble drugs - I. Prescription design","volume":"81","author":"Kawakami","year":"2002","journal-title":"J. Control. Release"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2021.02.030_bib0013","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ijpharm.2011.04.041","article-title":"Oil based nanocarrier for improved oral delivery of silymarin: in vitro and in vivo studies","volume":"413","author":"Parveen","year":"2011","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2021.02.030_bib0014","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0378-5173(99)00406-8","article-title":"Nonionic oil-in-water microemulsions: the effect of oil type on phase behaviour","volume":"198","author":"Warisnoicharoen","year":"2000","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2021.02.030_bib0015","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ejpb.2006.10.014","article-title":"Development and bioavailability assessment of ramipril nanoemulsion formulation","volume":"66","author":"Shafiq","year":"2007","journal-title":"Eur J. Pharm Biopharm"},{"key":"10.1016\/j.xphs.2021.02.030_bib0016","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.addr.2012.09.018","article-title":"Microemulsion-based media as novel drug delivery systems","volume":"64","author":"Lawrence","year":"2012","journal-title":"Adv. Drug Deliv. Rev"},{"issue":"2","key":"10.1016\/j.xphs.2021.02.030_bib0017","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0378-5173(00)00614-1","article-title":"Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q(10): formulation development and bioavailability assessment","volume":"212","author":"Kommuru","year":"2001","journal-title":"Int J Pharm"},{"issue":"15","key":"10.1016\/j.xphs.2021.02.030_bib0018","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1021\/jf400002x","article-title":"Preparation and Oral Bioavailability Study of Curcuminoid-Loaded Microemulsion","volume":"61","author":"Xiao","year":"2013","journal-title":"J. Agric. Food Chem"},{"issue":"11","key":"10.1016\/j.xphs.2021.02.030_bib0019","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.3390\/molecules25112616","article-title":"An improved nanoemulsion formulation containing Kojic Monooleate: optimization, characterization and in vitro studies","volume":"25","author":"Roselan","year":"2020","journal-title":"Molecules"},{"issue":"21\u201322","key":"10.1016\/j.xphs.2021.02.030_bib0020","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.drudis.2010.08.007","article-title":"Self-emulsifying drug delivery systems: an approach to enhance oral bioavailability","volume":"15","author":"Kohli","year":"2010","journal-title":"Drug Discov. Today"},{"issue":"2","key":"10.1016\/j.xphs.2021.02.030_bib0021","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ultsonch.2011.07.001","article-title":"Formulation development and optimization of a novel Cremophore EL-based nanoemulsion using ultrasound cavitation","volume":"19","author":"Tang","year":"2012","journal-title":"Ultrason Sonochem"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2021.02.030_bib0022","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ijpharm.2007.05.004","article-title":"Carbamazepine parenteral nanoemulsions prepared by spontaneous emulsification process","volume":"342","author":"Kelmann","year":"2007","journal-title":"Int J Pharm"},{"issue":"8","key":"10.1016\/j.xphs.2021.02.030_bib0023","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1021\/jf305143k","article-title":"Curcumin and genistein coloaded nanostructured lipid carriers: in vitro digestion and antiprostate cancer activity","volume":"61","author":"Aditya","year":"2013","journal-title":"J. Agric. Food Chem"},{"issue":"1","key":"10.1016\/j.xphs.2021.02.030_bib0024","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10787-020-00754-y","article-title":"Actions of Cannabis sativa L. fixed oil and nano-emulsion on venom-induced inflammation of Bothrops moojeni snake in rats","volume":"29","author":"de Oliveira Carvalho","year":"2020","journal-title":"Inflammopharmacology"},{"issue":"2","key":"10.1016\/j.xphs.2021.02.030_bib0025","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jconrel.2009.08.015","article-title":"Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation","volume":"140","author":"Yin","year":"2009","journal-title":"J. Control Release"},{"issue":"1","key":"10.1016\/j.xphs.2021.02.030_bib0026","first-page":"7754","article-title":"Thermosensitive Brinzolamide in situ Gel Nanoemulsions, in vitro and ex vivo Evaluation","volume":"11","author":"Mahboobian","year":"2021","journal-title":"Biointerface Res. Appl. Chem"},{"key":"10.1016\/j.xphs.2021.02.030_bib0027","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.2147\/IJN.S51578","article-title":"Nanoemulsion improves the oral bioavailability of baicalin in rats: in vitro and in vivo evaluation","volume":"8","author":"Zhao","year":"2013","journal-title":"Int J Nanomedicine"},{"issue":"3","key":"10.1016\/j.xphs.2021.02.030_bib0028","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.apsb.2017.02.002","article-title":"Self-microemulsifying drug delivery system for improving the bioavailability of huperzine A by lymphatic uptake","volume":"7","author":"Li","year":"2017","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"9","key":"10.1016\/j.xphs.2021.02.030_bib0029","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1023\/A:1016065715308","article-title":"Comparison between permeability coefficients in rat and human jejunum","volume":"13","author":"Fagerholm","year":"1996","journal-title":"Pharm. Res"},{"key":"10.1016\/j.xphs.2021.02.030_bib0030","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejps.2017.01.011","article-title":"Characterization, pharmacokinetics and tissue distribution of chlorogenic acid-loaded self-microemulsifying drug delivery system","volume":"100","author":"Chen","year":"2017","journal-title":"Eur. J. Pharm. Sci"},{"issue":"2","key":"10.1016\/j.xphs.2021.02.030_bib0031","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/sj.ejcn.1601547","article-title":"Bioavailability in humans of the flavanones hesperidin and narirutin after the ingestion of two doses of orange juice","volume":"57","author":"Manach","year":"2003","journal-title":"Eur J Clin Nutr"},{"issue":"5","key":"10.1016\/j.xphs.2021.02.030_bib0032","doi-asserted-by":"crossref","first-page":"e63348","DOI":"10.1371\/journal.pone.0063348","article-title":"Improvement of intestinal absorption of forsythoside a and chlorogenic acid by different carboxymethyl chitosan and chito-oligosaccharide, application to flos lonicerae - fructus forsythiae herb couple preparations","volume":"8","author":"Zhou","year":"2013","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.xphs.2021.02.030_bib0033","first-page":"1273","article-title":"Preparation and evaluation of spirulina polysaccharide nanoemulsions","volume":"42","author":"Wang","year":"2018","journal-title":"Int. J. Mol. Med"},{"issue":"2","key":"10.1016\/j.xphs.2021.02.030_bib0034","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1208\/s12249-011-9632-z","article-title":"Bioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in rats","volume":"12","author":"Chen","year":"2011","journal-title":"AAPS PharmSciTech"},{"issue":"5","key":"10.1016\/j.xphs.2021.02.030_bib0035","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0928-0987(02)00051-9","article-title":"Lipid-based formulations for intestinal lymphatic delivery","volume":"15","author":"O'Driscoll","year":"2002","journal-title":"Eur J. Pharm. Sci"},{"issue":"1","key":"10.1016\/j.xphs.2021.02.030_bib0036","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0169-409X(96)00492-9","article-title":"Uptake of drugs into the intestinal lymphatics after oral administration","volume":"25","author":"Porter","year":"1997","journal-title":"Adv. Drug Deliv. Rev"},{"issue":"4","key":"10.1016\/j.xphs.2021.02.030_bib0037","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ejps.2004.12.006","article-title":"Evaluation of a chylomicron flow blocking approach to investigate the intestinal lymphatic transport of lipophilic drugs","volume":"24","author":"Dahan","year":"2005","journal-title":"Eur. J. Pharm. Sci"},{"issue":"11","key":"10.1016\/j.xphs.2021.02.030_bib0038","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nrd4608","article-title":"From sewer to saviour - targeting the lymphatic system to promote drug exposure and activity","volume":"14","author":"Trevaskis","year":"2015","journal-title":"Nat. Rev. Drug Discov"},{"issue":"6","key":"10.1016\/j.xphs.2021.02.030_bib0039","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.addr.2007.09.007","article-title":"Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update","volume":"60","author":"Trevaskis","year":"2008","journal-title":"Adv. Drug Deliv. Rev"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354921001386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354921001386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:32:53Z","timestamp":1758360773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354921001386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0022354921001386"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2021.02.030","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanoemulsion for Improving the Oral Bioavailability of Hesperetin: Formulation Optimization and Absorption Mechanism","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2021.02.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}